ID: ALA4077816

Max Phase: Preclinical

Molecular Formula: C20H22N2

Molecular Weight: 290.41

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1ccc(CNC2CCc3c([nH]c4ccccc34)C2)cc1

Standard InChI:  InChI=1S/C20H22N2/c1-14-6-8-15(9-7-14)13-21-16-10-11-18-17-4-2-3-5-19(17)22-20(18)12-16/h2-9,16,21-22H,10-13H2,1H3

Standard InChI Key:  CPAIEIJZVFXFPO-UHFFFAOYSA-N

Associated Targets(Human)

Retinoblastoma-associated protein 82 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 290.41Molecular Weight (Monoisotopic): 290.1783AlogP: 4.12#Rotatable Bonds: 3
Polar Surface Area: 27.82Molecular Species: BASEHBA: 1HBD: 2
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.71CX LogP: 4.39CX LogD: 2.13
Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.75Np Likeness Score: -0.58

References

1. Kulkarni MR, Mane MS, Ghosh U, Sharma R, Lad NP, Srivastava A, Kulkarni-Almeida A, Kharkar PS, Khedkar VM, Pandit SS..  (2017)  Discovery of tetrahydrocarbazoles as dual pERK and pRb inhibitors.,  134  [PMID:28431342] [10.1016/j.ejmech.2017.02.062]

Source